Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation

Journal of Endocrinological Investigation

Volumn 30, Issue 3, 2007, Pages 173-180

  Thomas, D ^a   Liakos, V ^a,b   Vassiliou, E ^a,b   Hatzimarkou, F ^a   Tsatsoulis, A ^b   Kaldrimides, P ^a  

^a Metaxa Memorial Anticancer Research Hospital   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Differentiated thyroid carcinoma; Iodine 131 ablation; Thyroglobulin autoantibodies; Thyroid peroxidase autoantibodies; Thyroidectomy

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CANCER STAGING; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; RADIOFREQUENCY ABLATION; RADIOIMMUNOASSAY; SCHOOL CHILD; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY; TIME; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 34250622842     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347421     Document Type: Article

References (33)

1. Torrens J, Burch H. Serum Tg measurement. Utility in clinical practice. Endocrinol Metab Clin North Am 2001, 30: 429-67.
2. Chung JK, Park YJ, Kim TY, et al. Clinical significance of elevated level of serum Anti Tg in patients with DTC after thyroid ablation. Clin Endocrinol (Oxf) 2002, 57: 215-21.
3. Rodien P, Madec AM, Ruf J, et al. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab 1996, 81: 2595-600.
4. Baker J, Fosso CK. Immunological aspects of cancers arising from thyroid follicular cells. Endocr Rev 1993, 14: 729-46.
5. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998, 83: 1121-7.
6. Hocevar M, Auersperg M, Stanovnik L. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery. Eur J Surg Oncol 1997, 23: 280-10.
7. Chiovato L, Latrofa F, Braverman LA, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003, 139: 346-51.
8. Sheils OM, O'Eary J, Uhlmann V, Lattich K, Sweeny EC. Ret/PTC-1 activation in Hashimoto thyroiditis. Int J Surg Pathol 2000, 8: 185-92.
9. Powel DJ, Eisenlohr LC, Rothstein JL. A thyroid tumor-specific antigen formed by the fusion of two self-proteins. J Immunol 2003, 170: 861-9.
10. Tomer Y, Davies TF. Infection, thyroid disease and autoimmunity. Endocr Rev 1993, 14: 107-20.
11. Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol (Oxf) 2004, 60: 397-409.
12. Tsatsoulis A. The role of apoptosis in thyroid disease. Minerva Med 2002, 93: 169-80.
13. Armengol MP, Juan M, Lucas-Martin A, et al. Demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in cheomokine-containing active intrathyroidal germinal centers. Hum Pathol 2001, 159: 861-73.
14. Ringel MD, Ladenson PW, Levine MA. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 1998, 83: 4435-42.
15. Oliviery A, Marzullo A, Salbe GB, Gilardi E, Faccini C, Carta S. Isoelectric focusing and immunoblotting analysis of thyroglobulin from different thyroid disease. Thyroidol 1991, 3: 13-6.
16. Fugazzola L, Michalich A, Persani L, et al. High sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission. J Clin Endocrinol Metab 2002, 87: 3201-8.
17. Bugalho MJ, Domingues RS, Pinto AC, et al. Detection of thyroglobulin mRNAs transcripts in peripheral blood of individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 2001, 145: 409-13.
18. Macsween KF, Crawford DH. Epstein-Barr virus recent advances. Lancet Infect Dis 2002, 3: 131-40.
19. Nakamura M, Burastero SE, Ueki Y, Larrick JW, Notkins AL, Casali P. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoanibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J Immunol 1998, 141: 4165-72.
20. MacLahlan SM, Rapaport B. Evidence for a potential common T cell epitope between human thyroid peroxidase and human thyroglobulin with implications for the pathogenesis of autoimmune thyroid disease. Autoimmunity 1989, 5: 101-6.
21. Vojdani A, Rahimian P, Kahlor H, Mordechai E. Immunological cross reactivity between Candida albicans and human tissue. J Clin Lab Immunol 1996, 48: 1-15.
22. Bertalot G, Montresor G, Tampieri M, et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol (Oxf) 2004, 61: 650-2.
23. Villiers MB, Marche PN, Villiers CL. Improvement of long-lasting response and antibody affinity by the complexation of antigen with complement C3b. Inter Immunol 2003, 15: 91-5.
24. Nakra P, Manivel V, Vishwakarma RA, Rao KVS. B cell responses to a peptide epitope. X. Epiotope selection in a primary response is thermodynamically regulated. J Immunol 2000, 164: 5615-25.
25. Inaoki M, Sato S, Weitraub BC, Goodnow CC, Tedder TF. CD-19 regulated thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 2000, 186: 1923-31.
26. Fecteau JF, Neron S. CD40 stimulation of human peripheral B lymphocytes: distinct responses of naïve and memory B lymphocytes. J Immunol 2003, 171: 4621-9.
27. Barzon L, Boscaro M, Pacenti M, Taccaliti A, Palu G. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer. Int J Cancer 2004, 110: 914-20.
28. 131I whole body scanning. J Nucl Med 2005, 46: 1473-80.
29. Hobby P, Gardas A, Radomski R, McGregor AM, Banga JB, Sutton BJ. Identification of an immunodominant region recognized by human autoantibodies in a three-dimensional model of thyroid peroxidase. Endocrinology 2000, 141: 2018-26.
30. Bresson D, Cerutti M, Devauchelle G, et al. Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem 2003, 278: 9560-9.
31. Hammer J, Belunis C, Bolin D, et al. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc Natl Acad Sci 1994, 91: 4456-62.
32. Garcia KC, Teyton L, Wilson IA. Structural basis of T cell recognition. Ann Rev Immunol 1999, 17: 369-97.
33. Schneider F, Mariotti S, Ikekubo K, Kuma K. Iodine content of serum thyroglobulin in normal individuals and patients with thyroid cancer. J Clin Endocrinol Metab 1985, 57: 1251-6.